MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 37, 2008, Pages 14046-14051

  Bhoj, Vijay G ^a   Sun, Qinmiao ^a   Bhoj, Elizabeth J ^a   Somers, Cynthia ^b   Chen, Xiang ^a   Torres, Juan Pablo ^b   Mejias, Asuncion ^b   Gomez, Ana M ^b   Jafri, Hasan ^b   Ramilo, Octavio ^b   Chen, Zhijian J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adaptive immunity; IFN; RSV

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; IMMUNE DEFICIENCY; INNATE IMMUNITY; LUNG FIBROBLAST; LUNG INFECTION; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; VIRUS LOAD;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODY FORMATION; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNITY, NATURAL; LUNG DISEASES; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES;

EID: 52949131887     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804717105     Document Type: Article

References (31)

1. Pichlmair A, Reis e Sousa C (2007) Innate recognition of viruses. Immunity 27:370-383.
2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801.
3. Seth RB, Sun L, Chen ZJ (2006) Antiviral innate immunity pathways. Cell Res 16:141-147.
4. Pichlmair A, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
5. Hornung V, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
6. Kawai T, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988.
7. Meylan E, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
8. Xu LG, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740.
9. Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
10. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252.
11. Simoes EA, Carbonell-Estrany X (2003) Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 22:S13-S18; discussion S18-S20.
12. Murata Y, Falsey AR (2007) Respiratory syncytial virus infection in adults. Antivir Ther 12:659-670.
13. Welliver RC (2003) Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 143:S112-S117.
14. Openshaw PJ (2005) Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc Am Thorac Soc 2:121-125.
15. Collins PL, Murphy BR (2005) New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. Proc Am Thorac Soc 2:166-173.
16. Sun Q, et al. (2006) The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642.
17. Kato H, et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28.
18. Kumagai Y, et al. (2007) Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27:240-252.
19. Jafri HS, et al. (2004) Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189:1856-1865.
20. Rudd BD, et al. (2007) MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection. J Immunol 178:5820-5827.
21. Koyama S, et al. (2007) Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179:4711-4720.
22. Graham BS, Bunton LA, Wright PF, Karzon DT (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88:1026-1033.
23. Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Jr, Graham BS (2005) Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 337:335-343.
24. Jung A, et al. (2008) Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T cell response via MyD88. J Virol 82:196-206.
25. Jewell NA, et al. (2007) Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 81:9790-9800.
26. Smit JJ, Rudd BD, Lukacs NW (2006) Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203:1153-1159.
27. Wang H, Peters N, Schwarze J (2006) Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 177:6263-6270.
28. Medzhitov R, Janeway CA, Jr (1999) Innate immune induction of the adaptive immune response. Cold Spring Harb Symp Quant Biol 64:429-435.
29. Hoebe K, Janssen E, Beutler B (2004) The interface between innate and adaptive immunity. Nat Immunol 5:971-974.
30. Schulz O, et al. (2005) Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-892.
31. Schwarze J, et al. (1999) CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 162:4207-4211.